FDA product code QRX: Continuous Glucose Monitor Informed Insulin Dose Calculator
QRX is the FDA product code for continuous glucose monitor informed insulin dose calculator. It is a Class II device, regulated under 21 CFR 862.1358 and reviewed by the Clinical Chemistry panel. FDA has cleared 6 510(k) submissions under QRX, 6 in the last five years, from 4 different applicants. The average 510(k) review took 197 days (median 181); 159 days on average over the last three years. FDA has posted 2 recalls for QRX devices, 2 initiated in the last five years.
Definition
A continuous glucose monitor (CGM)-informed insulin dose calculator is a software device that calculates suggested insulin doses based on CGM values and/or other relevant information.
Classification
| Field | Value |
|---|---|
| Device name | Continuous Glucose Monitor Informed Insulin Dose Calculator |
| Device class | Class II |
| Regulation | 21 CFR 862.1358 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
510(k) clearances per year for QRX
| Year | Clearances | Avg. review days |
|---|---|---|
| 2022 | 2 | 212 |
| 2023 | 2 | 220 |
| 2025 | 1 | 75 |
| 2026 | 1 | 243 |
Compare with all 510(k) review times · Search every QRX clearance
Top QRX applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Insulet Corporation | 3 | 2023-10-18 |
| DreaMed Diabetes, Ltd. | 1 | 2026-09-08 |
| Dexcom, Inc. | 1 | 2025-11-18 |
| Welldoc, Inc. | 1 | 2023-08-11 |
Most recent QRX clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260062 | DreaMed Diabetes, Ltd. | MODI System | 2026-09-08 | 243 |
| K252818 | Dexcom, Inc. | Dexcom Smart Basal | 2025-11-18 | 75 |
| K231824 | Insulet Corporation | SmartBolus Calculator | 2023-10-18 | 119 |
| K222888 | Welldoc, Inc. | BlueStar CGM insulin dose calculator | 2023-08-11 | 322 |
| K222239 | Insulet Corporation | SmartBolus Calculator | 2022-08-19 | 24 |
Recalls for QRX devices
2 product recalls in 2 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2025-09-11.
| Year | Recalls |
|---|---|
| 2025 | 2 |
Frequently asked questions
What is FDA product code QRX?
QRX is the FDA product code for continuous glucose monitor informed insulin dose calculator. It is a Class II device, regulated under 21 CFR 862.1358 and reviewed by the Clinical Chemistry panel.
What device class is QRX?
Class II, regulation 21 CFR 862.1358. Typical premarket route: 510(k).
How long does a 510(k) take for product code QRX?
Across 6 cleared submissions the average was 197 days from receipt to decision (median 181).
Which companies have the most QRX clearances?
Insulet Corporation (3); DreaMed Diabetes, Ltd. (1); Dexcom, Inc. (1); Welldoc, Inc. (1).
Have QRX devices been recalled?
Yes: 2 product recalls across 2 recall events; the most recent began 2025-09-11.
Next steps
- Run an FDA pathway report with predicate devices for product code QRX
- Run a recall and safety report across every QRX manufacturer
- Watch product code QRX for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times